Ben Wolf will speak on the panel “Risky Business: Addressing 2025 Drug and Device Inspections” during this virtual program hosted by the Food & Drug Law Institute (FDLI).
This webinar prepares stakeholders for a transformative new phase in FDA’s inspection and enforcement practices. Shifts in these practices demand strategic foresight from leaders across drugs and device industries and preparedness to handle all types of inspection tools. This panel addresses the current state of FDA inspections and shifts in budgetary priorities and personnel count that will affect their approach and timing.
For more information, click here.